TrialHelicobacter2023

Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.

Lifen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.